The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Human Epidermal Growth Factor Enhances Healing of Diabetic Foot Ulcers
Abstract
OBJECTIVE—To study the healing effect of recombinant human epidermal growth factor (hEGF) on diabetic foot ulcers. RESEARCH DESIGN AND METHODS—A total of 127 consecutive patients were screened and 61 diabetic subjects were recruited into this double-blind randomized controlled study. Predetermined criteria were used for diagnosis and classification of the diabetic wound. The patients were randomized into three groups. All patients attended our Diabetes Ambulatory Care Center every other week for joint consultation with the diabetologist and the podiatrist. Group 1 (control) was treated with Actovegin 5% cream (Actovegin), group 2 with Actovegin plus 0.02% (wt/wt) hEGF, and group 3 with Actovegin plus 0.04% (wt/wt) hEGF. The study end point was the complete closure of the wound. Failure to heal was arbitrarily defined as incomplete healing after 12 weeks. RESULTS—Final data were obtained from 61 patients randomly assigned into three groups. The mean ages of the patients, wound sizes, wound duration, metabolic measurements, and comorbidities were comparable within groups, except that group 3 had more female patients. Mean follow-up for the patients was 24 weeks. Data were cutoff at 12 weeks, and results were analyzed by intention to treat. After 12 weeks, in group 1 (control) eight patients had complete healing, two patients underwent toe amputation, and nine had nonhealing ulcers. In group 2 (0.02% [wt/wt] hEGF) 12 patients experienced wound healing, 2 had toe amputations, and 7 had nonhealing ulcers. Some 20 of 21 patients in group 3 (0.04% [wt/wt] hEGF) showed complete wound healing. Healing rates were 42.10, 57.14, and 95% for the control, 0.02% (wt/wt) hEGF, and 0.04% (wt/wt) hEGF groups, respectively. Kaplan-Meier survival analysis suggested that application of cream with 0.04% (wt/wt) hEGF caused more ulcers to heal by 12 weeks and increased the rate of healing compared with the other treatments (log-rank test, P = 0.0003). CONCLUSIONS—Our data support the contention that application of hEGF-containing cream, in addition to good foot care from a multidisciplinary team, significantly enhances diabetic foot ulcer wound healing and reduces the healing time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
Wieman, T. J., Smiell, J. M., & Su, Y. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.822 · Cited by 682
The Epidemiology of Lower Extremity Amputations in Diabetic Individuals
Most, R. S., & Sinnock, P. (1983) · Diabetes Care · doi:10.2337/diacare.6.1.87 · Cited by 561
Hartemann, A., & Van, G. H. (2003) · PubMed · Cited by 550
The burden of diabetic foot ulcers
Reiber, G., Lipsky, B., & Gibbons, G. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00181-0 · Cited by 527
Growth factors and wound healing: Part II. Role in normal and chronic wound healing
Bennett, N. T., & Schultz, G. S. (1993) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80589-6 · Cited by 452
Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis
Margolis, D. J., Kantor, J., & Berlin, J. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.692 · Cited by 356
Sustained release of epidermal growth factor accelerates wound repair.
Buckley, A., Davidson, J. M., Kamerath, C. D., Wolt, T. B., & Woodward, S. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7340 · Cited by 310
Grotendorst, G. R., Martin, G. R., Pencev, D., Sodek, J., & Harvey, A. K. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112243 · Cited by 275
Mustoe, T. A., Pierce, G. F., Morishima, C., & Deuel, T. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115048 · Cited by 266
Cited by
Patel, S., Srivastava, S., Singh, M. R., & Singh, D. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108615 · Cited by 1,049
The molecular biology of chronic wounds and delayed healing in diabetes
Blakytny, R., & Jude, E. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01773.x · Cited by 632
Management of Diabetic Foot Ulcers
Alexiadou, K., & Doupis, J. (2012) · Diabetes Therapy · doi:10.1007/s13300-012-0004-9 · Cited by 565
Shiekh, P. A., Singh, A., & Kumar, A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120020 · Cited by 443
Controlled Growth Factor Delivery for Tissue Engineering
Tayalia, P., & Mooney, D. J. (2009) · Advanced Materials · doi:10.1002/adma.200900241 · Cited by 430
Metadata
- Authors
- Tsang, M. W., Wong, W. K. R., Hung, C. S., Lai, K.-M., Tang, W., Cheung, E. Y. N., Kam, G., Leung, L., Chan, C. W., Chu, C. M., & Lam, E. K. H.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-06-01
- Volume
- 26
- Issue
- 6
- Pages
- 1856-1861
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2170938576
- Cited by
- 271
- References
- 16
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Epidermal Growth Factor Enhances Healing of Diabetic Foot Ulcers. https://app.cochat.ai/papers/10.2337/diacare.26.6.1856
- The paper
- Tsang, M. W., Wong, W. K. R., Hung, C. S., Lai, K.-M., Tang, W., Cheung, E. Y. N., Kam, G., Leung, L., Chan, C. W., Chu, C. M., & Lam, E. K. H. (2003). Human Epidermal Growth Factor Enhances Healing of Diabetic Foot Ulcers. Diabetes Care. https://doi.org/10.2337/diacare.26.6.1856
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.